1
|
Xu Y, Aung HL, Hesam-Shariati N, Keay L, Sun X, Phu J, Honson V, Tully PJ, Booth A, Lewis E, Anderson CS, Anstey KJ, Peters R. Contrast Sensitivity, Visual Field, Color Vision, Motion Perception, and Cognitive Impairment: A Systematic Review. J Am Med Dir Assoc 2024; 25:105098. [PMID: 38908397 DOI: 10.1016/j.jamda.2024.105098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2023] [Revised: 02/07/2024] [Accepted: 05/12/2024] [Indexed: 06/24/2024]
Abstract
OBJECTIVES To examine relationships between visual function (ie, contrast sensitivity, visual field, color vision, and motion perception) and cognitive impairment, including any definition of "cognitive impairment," mild cognitive impairment, or dementia. DESIGN Systematic review and meta-analyses. SETTING AND PARTICIPANTS Any settings; participants with (cases) or without (controls) cognitive impairment. METHODS We searched 4 databases (to January 2024) and included published studies that compared visual function between cases and controls. Standardized mean differences (SMD) with 95% CIs were calculated where data were available. Data were sufficient for meta-analyses when cases were people with dementia. The Joanna Briggs Institute checklists were used for quality assessment. RESULTS Fifty-one studies/69 reports were included. Cross-sectional evidence shows that people with dementia had worse contrast sensitivity function and color vision than controls: measured by contrast sensitivity (log units) on letter charts, SMD -1.22 (95% CI -1.98, -0.47), or at varied spatial frequencies, -0.92 (-1.28, -0.57); and by pseudoisochromatic plates, -1.04 (-1.59, -0.49); color arrangement, -1.30 (-2.31, -0.29); or matching tests, -0.51 (-0.78, -0.24). They also performed more poorly on tests of motion perception, -1.20 (-1.73, -0.67), and visual field: mean deviation, -0.87 (-1.29, -0.46), and pattern standard deviation, -0.69 (-1.24, -0.15). Results were similar when cases were limited to participants with clinically diagnosed Alzheimer disease. Sources of bias included lack of clarity on study populations or settings and definitions of cognitive impairment. The 2 included longitudinal studies with follow-ups of approximately 10 years were of good quality but reported inconsistent results. CONCLUSIONS AND IMPLICATIONS In the lack of longitudinal data, cross-sectional studies indicate that individuals with cognitive impairment have poorer visual function than those with normal cognition. Additional longitudinal data are needed to understand whether poor visual function precedes cognitive impairment and the most relevant aspects of visual function, dementia pathologies, and domains of cognition.
Collapse
Affiliation(s)
- Ying Xu
- Neuroscience Research Australia, Sydney, Australia; School of Psychology, Faculty of Science, UNSW Sydney, Sydney, Australia; The George Institute for Global Health, UNSW Sydney, Sydney, Australia; Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia; Ageing Futures Institute, UNSW Sydney, Sydney, Australia; Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, Australia.
| | - Htein Linn Aung
- Neuroscience Research Australia, Sydney, Australia; Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia
| | - Negin Hesam-Shariati
- Neuroscience Research Australia, Sydney, Australia; School of Psychology, Faculty of Science, UNSW Sydney, Sydney, Australia
| | - Lisa Keay
- The George Institute for Global Health, UNSW Sydney, Sydney, Australia; Ageing Futures Institute, UNSW Sydney, Sydney, Australia; School of Optometry and Vision Science, UNSW Sydney, Sydney, Australia
| | - Xiaodong Sun
- Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Fundus Diseases, Shanghai, China; Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China; National Clinical Research Center for Ophthalmic Diseases, Shanghai, China
| | - Jack Phu
- School of Optometry and Vision Science, UNSW Sydney, Sydney, Australia; Center for Eye Health, UNSW Sydney, Sydney, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Concord Clinical School, Concord Repatriation General Hospital, Sydney, Australia
| | - Vanessa Honson
- School of Optometry and Vision Science, UNSW Sydney, Sydney, Australia
| | - Phillip J Tully
- School of Psychology, The University of New England, Armidale, Australia
| | - Andrew Booth
- School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom
| | - Ebony Lewis
- Neuroscience Research Australia, Sydney, Australia; School of Psychology, Faculty of Science, UNSW Sydney, Sydney, Australia; Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia; Ageing Futures Institute, UNSW Sydney, Sydney, Australia
| | - Craig S Anderson
- The George Institute for Global Health, UNSW Sydney, Sydney, Australia; Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia; The George Institute China, Peking University Health Science Center, Beijing, China; Neurology Department, Royal Prince Alfred Hospital, Sydney, Australia
| | - Kaarin J Anstey
- Neuroscience Research Australia, Sydney, Australia; School of Psychology, Faculty of Science, UNSW Sydney, Sydney, Australia; Ageing Futures Institute, UNSW Sydney, Sydney, Australia
| | - Ruth Peters
- Neuroscience Research Australia, Sydney, Australia; School of Psychology, Faculty of Science, UNSW Sydney, Sydney, Australia; The George Institute for Global Health, UNSW Sydney, Sydney, Australia; Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia; Ageing Futures Institute, UNSW Sydney, Sydney, Australia; School of Public Health, Imperial College London, London, United Kingdom
| |
Collapse
|
2
|
Katz CN, Schjetnan AGP, Patel K, Barkley V, Hoffman KL, Kalia SK, Duncan KD, Valiante TA. A corollary discharge mediates saccade-related inhibition of single units in mnemonic structures of the human brain. Curr Biol 2022; 32:3082-3094.e4. [PMID: 35779529 DOI: 10.1016/j.cub.2022.06.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 04/04/2022] [Accepted: 06/08/2022] [Indexed: 11/18/2022]
Abstract
Despite the critical link between visual exploration and memory, little is known about how neuronal activity in the human mesial temporal lobe (MTL) is modulated by saccades. Here, we characterize saccade-associated neuronal modulations, unit-by-unit, and contrast them to image onset and to occipital lobe neurons. We reveal evidence for a corollary discharge (CD)-like modulatory signal that accompanies saccades, inhibiting/exciting a unique population of broad-/narrow-spiking units, respectively, before and during saccades and with directional selectivity. These findings comport well with the timing, directional nature, and inhibitory circuit implementation of a CD. Additionally, by linking neuronal activity to event-related potentials (ERPs), which are directionally modulated following saccades, we recontextualize the ERP associated with saccades as a proxy for both the strength of inhibition and saccade direction, providing a mechanistic underpinning for the more commonly recorded saccade-related ERP in the human brain.
Collapse
Affiliation(s)
- Chaim N Katz
- Krembil Brain Institute, Toronto Western Hospital (TWH), Toronto, ON M5T 1M8, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada; CRANIA, University Health Network and University of Toronto, Toronto, ON M5G 2A2, Canada; Faculty of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada
| | - Andrea G P Schjetnan
- Krembil Brain Institute, Toronto Western Hospital (TWH), Toronto, ON M5T 1M8, Canada; CRANIA, University Health Network and University of Toronto, Toronto, ON M5G 2A2, Canada
| | - Kramay Patel
- Krembil Brain Institute, Toronto Western Hospital (TWH), Toronto, ON M5T 1M8, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada; Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada; CRANIA, University Health Network and University of Toronto, Toronto, ON M5G 2A2, Canada
| | - Victoria Barkley
- Krembil Brain Institute, Toronto Western Hospital (TWH), Toronto, ON M5T 1M8, Canada; CRANIA, University Health Network and University of Toronto, Toronto, ON M5G 2A2, Canada
| | - Kari L Hoffman
- Department of Psychology, Vanderbilt University, Nashville, TN 37240, USA
| | - Suneil K Kalia
- Krembil Brain Institute, Toronto Western Hospital (TWH), Toronto, ON M5T 1M8, Canada; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON M5S 1A1, Canada; CRANIA, University Health Network and University of Toronto, Toronto, ON M5G 2A2, Canada; The KITE Research Institute, University Health Network, Toronto, ON M5G 2A2, Canada
| | - Katherine D Duncan
- Department of Psychology, University of Toronto, Toronto, ON M5S 3G3, Canada
| | - Taufik A Valiante
- Krembil Brain Institute, Toronto Western Hospital (TWH), Toronto, ON M5T 1M8, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON M5S 1A1, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON M5S 1A8, Canada; Electrical and Computer Engineering, University of Toronto, Toronto, ON M5S 3G4, Canada; CRANIA, University Health Network and University of Toronto, Toronto, ON M5G 2A2, Canada; The KITE Research Institute, University Health Network, Toronto, ON M5G 2A2, Canada; Max Planck-University of Toronto Center for Neural Science and Technology, Toronto, ON, Canada.
| |
Collapse
|
3
|
Almario G, Piñero DP. Impact of Alzheimer's Disease in Ocular Motility and Visual Perception: A Narrative Review. Semin Ophthalmol 2021; 37:436-446. [PMID: 34779338 DOI: 10.1080/08820538.2021.2002371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
PURPOSE Alzheimer's disease (AD) is a neurodegenerative disease generating a progressive neuronal loss as well as cognitive deficiencies. This disease can be accompanied by ocular manifestations, including alterations in ocular motility and visual perception. The aim of the current review article was to collect all the information about these alterations and to analyze if there is scientific evidence supporting the potential use of these changes as biomarkers of the disease. METHODS A bibliographic search was performed using two different databases, Pubmed and Google Scholar, as well as a search of material in non-peer reviewed journals about Alzheimer's and Neurology. A total of 227 articles were found in the initial search, but only 76 were included considering their relevance according to the purpose of the reviewResults: This narrative review describes the findings obtained in this area to this date, confirming that deficiencies in saccades is the most common condition among AD patients. Furthermore, other visual alterations have also been reported in these patients, including a compromise of visual acuity and contrast sensitivity, fluctuations of colour vision, stereopsis impairment and visual field losses. Likewise, other complex visuo-spatial and visuo-perceptual impairments can be present. More studies are still needed to understand better what type of changes occurs in ocular alignment, binocularity, and fixation pattern in AD patients. CONCLUSIONS AD is associated to visual perception and ocular motility alterations. All the scientific information found in this review should be considered as a guide for designing future studies and to define adequate clinical protocols for the visual evaluation of patients with AD, considering the cognitive limitations that are normally present in this type of patients.
Collapse
Affiliation(s)
- Gemma Almario
- Department of Optics, Pharmacology and Anatomy, University of Alicante, Alicante, Spain.,Punto Óptico, Elche, Alicante, Spain
| | - David P Piñero
- Department of Optics, Pharmacology and Anatomy, University of Alicante, Alicante, Spain.,Department of Ophthalmology, Vithas Medimar International Hospital, Alicante, Spain
| |
Collapse
|